In Vivo Bioactivity-guided Fractionation, HPLC Profiling, and In silico Evaluation of Anti-ulcer Compounds from Aqueous Extract of Acacia nilotica Pods
Bioactive Molecules and Pharmaceuticals · 19.06.2026 · 3 (6) · 97-113
DOI: 10.31989/bmp.v3i6.2047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioactive Molecules and Pharmaceuticals, online erschienen am 19.06.2026. Verfasst von Azeemat Abdulazeez und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The introduction of conventional anti-ulcer pharmacotherapy has markedly reduced the incidence and severity of gastric ulcers. However, ulcer recurrence and persistent side effects remain important concerns. Acacia nilotica, a medicinal plant with a broad spectrum of pharmacological activities, has shown promising potential in mitigating ulcerative conditions, specifically through its gastroprotective mechanisms.
Objectives
This study aimed to evaluate the aqueous extract of Acacia nilotica pods for anti-ulcer potential using in vivo bioactivity-guided fractionation, HPLC profiling and in silico analyses.
Methods
The aqueous extract was fractionated using solvents of increasing polarity, and the resulting n-butanol fraction showed the highest gastroprotection (76.84%) and ulcer healing (62.84%) effects in an ethanol-induced ulcer model. Further purification of the n-butanol fraction using silica gel column chromatography yielded 23 sub-fractions that were pooled together to three major sub-fractions; (FA, FB and FC).
Results
FB exhibited the highest gastroprotection (96.08%) and ulcer healing (87.44%) effect. HPLC analysis of FB revealed the presence of catechin, gallic acid, and quercetin-3-galotoside. The compounds were subjected to in silico docking against H+/K+-ATPase where, epicatechin showed the highest binding affinity (-11.367 kcal/mol), followed by quercetin-3-galotoside (-10.198 kcal/mol), both surpassing the standard inhibitor omeprazole (-5.644 kcal/mol). MMGBSA and ADMET analyses confirmed epicatechin superior binding energy and favorable pharmacokinetic profile over the other hit compounds.
Conclusion
The findings establish a direct link between bioactive polyphenols in Acacia nilotica an antiulcer activity, with evidence supporting proton pump inhibition as a key mechanism. Novelty of the Study: This study applies a bioactivity-guided approach to link the anti-ulcer effects of Acacia nilotica pods to specific polyphenolic compounds and their interaction with H⁺/K⁺-ATPase. The identification of Fraction B as the most active fraction, supported by HPLC profiling and in silico analysis, provides mechanistic insight into proton pump inhibition by plant-derived bioactives. Keywords: Bioactivity-guided fractionation, Acacia nilotica, Polyphenols, H+/k+ ATPase inhibition, Gastroprotection, Molecular docking, Functional food bioactives
Zitieren
APA
Abdulazeez, A., Alli, A., Idakwoji, P. A., & Balogun, E. (2026). In Vivo Bioactivity-guided Fractionation, HPLC Profiling, and In silico Evaluation of Anti-ulcer Compounds from Aqueous Extract of Acacia nilotica Pods. Bioactive Molecules and Pharmaceuticals, 3(6), 97-113. https://doi.org/10.31989/bmp.v3i6.2047
Vancouver
Abdulazeez A, Alli A, Idakwoji PA, Balogun E. In Vivo Bioactivity-guided Fractionation, HPLC Profiling, and In silico Evaluation of Anti-ulcer Compounds from Aqueous Extract of Acacia nilotica Pods. Bioactive Molecules and Pharmaceuticals. 2026;3(6):97-113. doi:10.31989/bmp.v3i6.2047
BibTeX
@article{Abdulazeez2026,
author = {Abdulazeez, Azeemat and Alli, Abdulhameed and Idakwoji, Precious Adejoh and Balogun, Elizabeth},
title = {In Vivo Bioactivity-guided Fractionation, HPLC Profiling, and In silico Evaluation of Anti-ulcer Compounds from Aqueous Extract of Acacia nilotica Pods},
journal = {Bioactive Molecules and Pharmaceuticals},
year = {2026},
volume = {3},
number = {6},
pages = {97--113},
doi = {10.31989/bmp.v3i6.2047}
}
EUVIMED